Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Atovaquone belongs to the class of naphthoquinones with a broad-spectrum activity against parasitic infections including malaria, toxoplasmosis and Pneumocystis pneumonia. It is a potent antiprotozoal compound which aids in collapsing the mitochondrial membrane potential in a malaria parasite.
1.Krause PJ, Lepore T, Sikand VK, Gadbaw Jr J, Burke G, Telford 3rd SR, Brassard P, Pearl D, Azlanzadeh J, Christianson D et al.. (2000) Atovaquone and azithromycin for the treatment of babesiosis.. N Engl J Med, 343 (20):(1454-8). [PMID:11078770]
2.Boggild AK, Parise ME, Lewis LS, Kain KC. (2007) Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II).. Am J Trop Med Hyg, 76 (2):(208-23). [PMID:17297027]
3.Painter HJ, Morrisey JM, Mather MW, Vaidya AB. (2007) Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum.. Nature, 446 (7131):(88-91). [PMID:17330044]
4.Fisher N, Abd Majid R, Antoine T, Al-Helal M, Warman AJ, Johnson DJ, Lawrenson AS, Ranson H, O'Neill PM, Ward SA et al.. (2012) Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression.. J Biol Chem, 287 (13):(9731-41). [PMID:22282497]
5.Canfield CJ, Pudney M, Gutteridge WE. (1995) Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro.. Exp Parasitol, 80 (3):(373-81). [PMID:7729473]
6.Vaidya AB, Lashgari MS, Pologe LG, Morrisey J. (1993) Structural features of Plasmodium cytochrome b that may underlie susceptibility to 8-aminoquinolines and hydroxynaphthoquinones.. Mol Biochem Parasitol, 58 (1):(33-42). [PMID:8459834]
7.Hughes W, Leoung G, Kramer F, Bozzette SA, Safrin S, Frame P, Clumeck N, Masur H, Lancaster D, Chan C et al.. (1993) Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.. N Engl J Med, 328 (21):(1521-7). [PMID:8479489]
8.Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB, Canfield CJ. (1996) Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand.. Am J Trop Med Hyg, 54 (1):(62-6). [PMID:8651372]
9.Srivastava IK, Rottenberg H, Vaidya AB. (1997) Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite.. J Biol Chem, 272 (7):(3961-6). [PMID:9020100]
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
G2410063